ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BHST vs IDXG // RETURN ON INVESTED CAPITAL (ROIC)

BioHarvest Sciences Inc. (NASDAQ) VS. Interpace Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: BHST 2 — IDXG 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: IDXG
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHST VS. IDXG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BHST IDXG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 59.30% 62.30% -3.00 IDXG /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% 16.20% -51.20 IDXG /roic <GO>
EV/EBITDA & P/E Valuation — 4.7x — TIE /valuation <GO>
Free Cash Flow Yield — 23.60% — TIE /fcf-yield <GO>
Operating Margin -16.20% 10.50% -26.70 IDXG /operating-margins <GO>
Net Profit Margin -32.30% 63.50% -95.80 IDXG /net-margins <GO>
Revenue Growth (YoY) 37.00% -17.50% +54.50 BHST /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 6/9 -1.00 IDXG /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.0 50.0 -1.91 IDXG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $37.6M $23.2M $14.4M BHST /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BHST REV IDXG REV BHST GROSS % IDXG GROSS % BHST FCF IDXG FCF
FY 2025 $34.5M $38.7M 59.3% 62.3% -$9.6M $5.5M
FY 2024 $25.2M $46.9M 55.4% 63.8% -$9.5M $3.8M
FY 2023 $12.7M $40.0M — — -$8.5M $3.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHST // BETA —
IDXG // BETA —